chrX-50596825-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_020717.5(SHROOM4):āc.4352A>Gā(p.Tyr1451Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000273 in 1,209,757 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000018 ( 0 hom., 1 hem., cov: 24)
Exomes š: 0.000028 ( 0 hom. 10 hem. )
Consequence
SHROOM4
NM_020717.5 missense
NM_020717.5 missense
Scores
9
5
3
Clinical Significance
Conservation
PhyloP100: 4.46
Genes affected
SHROOM4 (HGNC:29215): (shroom family member 4) This gene encodes a member of the APX/Shroom family, which contain an N-terminal PDZ domain and a C-terminal ASD2 motif. The encoded protein may play a role in cytoskeletal architecture. Mutations in this gene have been linked to the X-linked Stocco dos Santos syndrome characterized by cognitive disabilities. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.961
BS2
High Hemizygotes in GnomAdExome4 at 10 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHROOM4 | NM_020717.5 | c.4352A>G | p.Tyr1451Cys | missense_variant | 9/9 | ENST00000376020.9 | NP_065768.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHROOM4 | ENST00000376020.9 | c.4352A>G | p.Tyr1451Cys | missense_variant | 9/9 | 2 | NM_020717.5 | ENSP00000365188 | P1 | |
SHROOM4 | ENST00000289292.11 | c.4352A>G | p.Tyr1451Cys | missense_variant | 9/10 | 1 | ENSP00000289292 | P1 | ||
SHROOM4 | ENST00000460112.3 | c.4004A>G | p.Tyr1335Cys | missense_variant | 8/8 | 5 | ENSP00000421450 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112451Hom.: 0 Cov.: 24 AF XY: 0.0000289 AC XY: 1AN XY: 34595
GnomAD3 genomes
AF:
AC:
2
AN:
112451
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34595
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000110 AC: 2AN: 182409Hom.: 0 AF XY: 0.0000299 AC XY: 2AN XY: 66949
GnomAD3 exomes
AF:
AC:
2
AN:
182409
Hom.:
AF XY:
AC XY:
2
AN XY:
66949
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000283 AC: 31AN: 1097306Hom.: 0 Cov.: 31 AF XY: 0.0000276 AC XY: 10AN XY: 362766
GnomAD4 exome
AF:
AC:
31
AN:
1097306
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
362766
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112451Hom.: 0 Cov.: 24 AF XY: 0.0000289 AC XY: 1AN XY: 34595
GnomAD4 genome
AF:
AC:
2
AN:
112451
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34595
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.4352A>G (p.Y1451C) alteration is located in exon 9 (coding exon 9) of the SHROOM4 gene. This alteration results from a A to G substitution at nucleotide position 4352, causing the tyrosine (Y) at amino acid position 1451 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
T
PROVEAN
Pathogenic
D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;.
Vest4
MutPred
Loss of phosphorylation at Y1451 (P = 0.0384);Loss of phosphorylation at Y1451 (P = 0.0384);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at